Published :
Tables : 120
Figures : 50
Category : Healthcare
No. of Pages : 180
Report Code : HC-1271
Clinical Microbiology Market Introduction: Global Clinical Microbiology Market is estimated to value over USD 5.9 billion by 2027 end and register a CAGR of over 6.2% during the forecast period 2020 to 2027. Increasing air pollution levels with rapid industrialization is leading into an expeditious escalation in occurrences of respiratory diseases. Furthermore, amongst all kinds of infections, respiratory diseases are transmitted rapidly as the contagious pathogens are easily passed on from one person to another. Therefore, this segment is predicted to showcase substantial augmentation during the forecast period. Moreover, rising incidences of infectious diseases in developing as well as developed countries which is another factor contributing to the segment growth. Additionally, as per a few observations that were published in the Journal of the American Medical Association (AMA), persistent respiratory diseases were the reason for over 1 in every 20 deaths in 2015. In 2013, around USD 130 billion of healthcare expenditures were related to these diseases. Blood tests, bronchoscopy and biopsy are commonly utilized tools for diagnosing respiratory diseases. Thus, increasing incidences of persistent respiratory diseases is an integral factor stimulating the global clinical microbiology market growth. The market is segmented on the basis of end users as academic and research institutes, custom lab service providers and hospitals and diagnostic centres. The custom lab service providers are predicted to showcase the highest proliferation over the forecast period due to the drug testing processes that are continuously outsources to laboratory services by pharmaceutical companies, benefits provided by the procedures of advanced molecular technology-based instruments like NGS and PCR in discovering drugs, rising number of clinical trials based on microbiology and the increasing number of service providers of custom labs across key market regions. Key market players included in the global clinical microbiology industry are Biomerieux, Danaher Corp., Becton, Dickinson and Co., Abbott, Roche Diagnostics, Bruker, Hologic, Bio-Rad, Qiagen, Thermo Fisher Scientific, Agilent, Merck KGaA, Shimadzu, 3M, Neogen. Clinical Microbiology Market Segmentation: By Application Pharmaceutical Applications Food Testing Applications Clinical Applications Energy Applications Chemical & Material Manufacturing Applications Environmental Applications By Product Instruments Laboratory Instruments Incubators Gram Stainers Bacterial Colony Counters Autoclave Sterilizers Microbial Air Samplers Anaerobic Culture Systems Petri Dish Fillers Blood Culture Systems Microbial Culture Systems Other Laboratory Instruments Microbiology Analyzers Molecular Diagnostic Instruments Microscopes Mass Spectrometers Reagents Pathogen-Specific Kits General Reagents By Indication Respiratory Diseases Bloodstream Infections Gastrointestinal Diseases Sexually Transmitted Diseases Urinary Tract Infections Periodontal Diseases Other Indications By End User Hospitals & Diagnostic Centres Custom Lab Service Providers Academic & Research Institutes By Region North America Europe Asia Pacific Rest of the World FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global clinical microbiology market by application, by product, by indication, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Global Clinical Microbiology Market is estimated to value over USD 5.9 billion by 2027 end and register a CAGR of over 6.2% during the forecast period 2020 to 2027.
Increasing air pollution levels with rapid industrialization is leading into an expeditious escalation in occurrences of respiratory diseases. Furthermore, amongst all kinds of infections, respiratory diseases are transmitted rapidly as the contagious pathogens are easily passed on from one person to another. Therefore, this segment is predicted to showcase substantial augmentation during the forecast period. Moreover, rising incidences of infectious diseases in developing as well as developed countries which is another factor contributing to the segment growth.
Additionally, as per a few observations that were published in the Journal of the American Medical Association (AMA), persistent respiratory diseases were the reason for over 1 in every 20 deaths in 2015. In 2013, around USD 130 billion of healthcare expenditures were related to these diseases. Blood tests, bronchoscopy and biopsy are commonly utilized tools for diagnosing respiratory diseases. Thus, increasing incidences of persistent respiratory diseases is an integral factor stimulating the global clinical microbiology market growth.
The market is segmented on the basis of end users as academic and research institutes, custom lab service providers and hospitals and diagnostic centres. The custom lab service providers are predicted to showcase the highest proliferation over the forecast period due to the drug testing processes that are continuously outsources to laboratory services by pharmaceutical companies, benefits provided by the procedures of advanced molecular technology-based instruments like NGS and PCR in discovering drugs, rising number of clinical trials based on microbiology and the increasing number of service providers of custom labs across key market regions.
Key market players included in the global clinical microbiology industry are Biomerieux, Danaher Corp., Becton, Dickinson and Co., Abbott, Roche Diagnostics, Bruker, Hologic, Bio-Rad, Qiagen, Thermo Fisher Scientific, Agilent, Merck KGaA, Shimadzu, 3M, Neogen.
Clinical Microbiology Market Segmentation:
By Application
By Product
By Indication
By End User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Markets Covered 1.3.2 Geographic Scope 1.3.3 Years Considered for the Study 1.4 Currency and Pricing 1.5 Stakeholders 2 Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.1.2.2 Breakdown of Primaries 2.2 Opportunity Indicators 2.2.1 Introduction 2.2.2 Demand-Side Analysis 2.2.2.1 Burden of Infectious Diseases 2.2.2.2 Healthcare Expenditure Patterns 2.2.2.3 Rapid Growth in the Geriatric Population 2.2.3 Supply-Side Analysis 2.2.3.1 Number of New Clinical Microbiology Products Launched 2.3 Market Size Estimation 2.3.1 Bottom-Up Approach 2.3.2 Top-Down Approach 2.4 Market Breakdown and Data Triangulation 2.5 Research Limitations and Assumptions 2.5.1 Limitations 2.5.2 Assumptions 3 Executive Summary 4 Exclusive Insights 4.1 Microbiology Testing Market (2020–2027) 4.2 Microbiology Testing Market, By Application, 2020–2027 (USD Billion) 4.3 Clinical Microbiology Market (2020–2027) 4.4 Clinical Microbiology Products Market, By Region (2020) 4.5 Market, By Indication, 2020 vs 2027 (USD Million) 4.6 Geographic Analysis: Market, By End User, 2020 vs 2027 (USD Million) 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Technological Advancements in Disease Diagnostics 5.2.1.2 Rising Incidence of Infectious Diseases and Growing Outbreaks of Epidemics 5.2.1.3 Increased Funding and Public-Private Investments 5.2.2 Restraints 5.2.2.1 Limited Reimbursement Policies for Microbiology Testing Procedures 5.2.2.2 Budget Cuts, Customs Duties, and Additional Taxes Levied 5.2.3 Opportunities 5.2.3.1 Emerging Countries 5.2.4 Challenges 5.2.4.1 Operational Barriers Related to the Use of Diagnostic Tests 5.2.4.2 Bundled Sales of Microbiology Testing Products—A Key Challenge for Small and Emerging Reagent Manufacturers 6 Microbiology Testing Market, By Application 6.1 Introduction 6.2 Pharmaceutical Applications 6.3 Food Testing Applications 6.4 Clinical Applications 6.5 Energy Applications 6.6 Chemical & Material Manufacturing Applications 6.7 Environmental Applications 7 Market, By Product 7.1 Introduction 7.2 Instruments 7.2.1 Laboratory Instruments 7.2.1.1 Incubators 7.2.1.2 Gram Stainers 7.2.1.3 Bacterial Colony Counters 7.2.1.4 Autoclave Sterilizers 7.2.1.5 Microbial Air Samplers 7.2.1.6 Anaerobic Culture Systems 7.2.1.7 Petri Dish Fillers 7.2.1.8 Blood Culture Systems 7.2.1.9 Microbial Culture Systems 7.2.1.10 Other Laboratory Instruments 7.2.2 Microbiology Analyzers 7.2.2.1 Molecular Diagnostic Instruments 7.2.2.2 Microscopes 7.2.2.3 Mass Spectrometers 7.3 Reagents 7.3.1 Pathogen-Specific Kits 7.3.2 General Reagents 8 Market, By Indication 8.1 Introduction 8.2 Respiratory Diseases 8.3 Bloodstream Infections 8.4 Gastrointestinal Diseases 8.5 Sexually Transmitted Diseases 8.6 Urinary Tract Infections 8.7 Periodontal Diseases 8.8 Other Indications 9 Market, By End User 9.1 Introduction 9.2 Hospitals & Diagnostic Centers 9.3 Custom Lab Service Providers 9.4 Academic & Research Institutes 10 Microbiology Testing Market, By Region 10.1 Introduction 10.2 North America 10.2.1 US 10.2.2 Canada 10.3 Europe 10.3.1 Germany 10.3.2 UK 10.3.3 France 10.3.4 Rest of Europe 10.4 Asia Pacific 10.4.1 Japan 10.4.2 China 10.4.3 India 10.4.4 Rest of APAC 10.5 Rest of the World (RoW) 10.5.1 Latin America 10.5.2 Middle East & Africa 11 Competitive Landscape 11.1 Overview 11.2 Market Share Analysis 11.3 Competitive Scenario 11.3.1 Key Product Launches & Approvals (2017–2020) 11.3.2 Key Agreements, Partnerships, & Collaborations (2017–2020) 11.3.3 Key Acquisitions & Divestments (2017–2020) 11.3.4 Key Expansions (2017–2020) 12 Company Profiles 12.1 Biomérieux 12.2 Danaher Corporation 12.3 Becton, Dickinson and Company 12.4 Abbott 12.5 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.) 12.6 Bruker 12.7 Hologic 12.8 Bio-Rad 12.9 Qiagen 12.10 Thermo Fisher Scientific 12.11 Agilent 12.12 Merck KGaA 12.13 Shimadzu 12.14 3M 12.15 Neogen Chapter 13 Research Finding and Conclusion Chapter 14 Research Methodology Chapter 15 Research Data Source
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency and Pricing
1.5 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Opportunity Indicators
2.2.1 Introduction
2.2.2 Demand-Side Analysis
2.2.2.1 Burden of Infectious Diseases
2.2.2.2 Healthcare Expenditure Patterns
2.2.2.3 Rapid Growth in the Geriatric Population
2.2.3 Supply-Side Analysis
2.2.3.1 Number of New Clinical Microbiology Products Launched
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Research Limitations and Assumptions
2.5.1 Limitations
2.5.2 Assumptions
3 Executive Summary
4 Exclusive Insights
4.1 Microbiology Testing Market (2020–2027)
4.2 Microbiology Testing Market, By Application, 2020–2027 (USD Billion)
4.3 Clinical Microbiology Market (2020–2027)
4.4 Clinical Microbiology Products Market, By Region (2020)
4.5 Market, By Indication, 2020 vs 2027 (USD Million)
4.6 Geographic Analysis: Market, By End User, 2020 vs 2027 (USD Million)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Technological Advancements in Disease Diagnostics
5.2.1.2 Rising Incidence of Infectious Diseases and Growing Outbreaks of Epidemics
5.2.1.3 Increased Funding and Public-Private Investments
5.2.2 Restraints
5.2.2.1 Limited Reimbursement Policies for Microbiology Testing Procedures
5.2.2.2 Budget Cuts, Customs Duties, and Additional Taxes Levied
5.2.3 Opportunities
5.2.3.1 Emerging Countries
5.2.4 Challenges
5.2.4.1 Operational Barriers Related to the Use of Diagnostic Tests
5.2.4.2 Bundled Sales of Microbiology Testing Products—A Key Challenge for Small and Emerging Reagent Manufacturers
6 Microbiology Testing Market, By Application
6.1 Introduction
6.2 Pharmaceutical Applications
6.3 Food Testing Applications
6.4 Clinical Applications
6.5 Energy Applications
6.6 Chemical & Material Manufacturing Applications
6.7 Environmental Applications
7 Market, By Product
7.1 Introduction
7.2 Instruments
7.2.1 Laboratory Instruments
7.2.1.1 Incubators
7.2.1.2 Gram Stainers
7.2.1.3 Bacterial Colony Counters
7.2.1.4 Autoclave Sterilizers
7.2.1.5 Microbial Air Samplers
7.2.1.6 Anaerobic Culture Systems
7.2.1.7 Petri Dish Fillers
7.2.1.8 Blood Culture Systems
7.2.1.9 Microbial Culture Systems
7.2.1.10 Other Laboratory Instruments
7.2.2 Microbiology Analyzers
7.2.2.1 Molecular Diagnostic Instruments
7.2.2.2 Microscopes
7.2.2.3 Mass Spectrometers
7.3 Reagents
7.3.1 Pathogen-Specific Kits
7.3.2 General Reagents
8 Market, By Indication
8.1 Introduction
8.2 Respiratory Diseases
8.3 Bloodstream Infections
8.4 Gastrointestinal Diseases
8.5 Sexually Transmitted Diseases
8.6 Urinary Tract Infections
8.7 Periodontal Diseases
8.8 Other Indications
9 Market, By End User
9.1 Introduction
9.2 Hospitals & Diagnostic Centers
9.3 Custom Lab Service Providers
9.4 Academic & Research Institutes
10 Microbiology Testing Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of APAC
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.2 Middle East & Africa
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Key Product Launches & Approvals (2017–2020)
11.3.2 Key Agreements, Partnerships, & Collaborations (2017–2020)
11.3.3 Key Acquisitions & Divestments (2017–2020)
11.3.4 Key Expansions (2017–2020)
12 Company Profiles
12.1 Biomérieux
12.2 Danaher Corporation
12.3 Becton, Dickinson and Company
12.4 Abbott
12.5 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
12.6 Bruker
12.7 Hologic
12.8 Bio-Rad
12.9 Qiagen
12.10 Thermo Fisher Scientific
12.11 Agilent
12.12 Merck KGaA
12.13 Shimadzu
12.14 3M
12.15 Neogen
Chapter 13 Research Finding and Conclusion
Chapter 14 Research Methodology
Chapter 15 Research Data Source
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics